Bioactive lipids in trypanosoma cruzi infection

Advances in Parasitology

Volumn 76, Issue , 2011, Pages 1-31

  Machado, Fabiana S ^a   Mukherjee, Shankar ^b   Weiss, Louis M ^b   Tanowitz, Herbert B ^b   Ashton, Anthony W ^b,c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chagas disease; Chagas heart disease; Eicosanoids; Inflammation; Lipoxins; Thromboxane; Trypanosoma cruzi

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; G PROTEIN COUPLED RECEPTOR; ICOSANOID; INDOMETACIN; LIPID; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPID; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN H2; THROMBOXANE; THROMBOXANE A2;

ACUTE DISEASE; ADAPTIVE IMMUNITY; BOOK; CELLULAR IMMUNITY; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE MODEL; ENZYME INHIBITION; ENZYME METABOLISM; FATTY ACID METABOLISM; HUMAN; ICOSANOID METABOLISM; IMMUNOMODULATION; IMMUNOREGULATION; INSECT; KNOCKOUT MOUSE; LIPID METABOLISM; MORTALITY; NONHUMAN; PARASITE IMMUNITY; PARASITE LOAD; PARASITE VECTOR; PARASITEMIA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SIDE EFFECT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TRYPANOSOMA CRUZI;

MUS; PROTOZOA; TRYPANOSOMA CRUZI;

EID: 80052175633     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385895-5.00001-3     Document Type: Chapter

References (136)

1. Abdalla G.K., Faria G.E., Silva K.T., Castro E.C., Reis M.A., Michelin M.A. Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection. Exp. Parasitol. 2008, 118:514-521.
2. Aliberti J. Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nat. Rev. Immunol. 2005, 5:162-170.
3. Aliberti J., Serhan C., Sher A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 2002, 196:1253-1262.
4. Aliberti J., Hieny S., Reis e Sousa C., Serhan C.N., Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 2002, 3:76-82.
5. Andrade H.M., Murta S.M., Chapeaurouge A., Perales J., Nirde P., Romanha A.J. Proteomic analysis of Trypanosoma cruzi resistance to Benznidazole. J. Proteome Res. 2008, 7:2357-2367.
6. Ashton A.W., Mukherjee S., Nagajyothi F.N., Huang H., Braunstein V.L., Desruisseaux M.S., et al. Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J. Exp. Med. 2007, 204:929-940.
7. Azambuja P., Garcia E.S. Trypanosoma rangeli interactions within the vector Rhodnius prolixus: a mini review. Mem. Inst. Oswaldo Cruz 2005, 100:567-572.
8. Azambuja P., Ratcliffe N.A., Garcia E.S. Towards an understanding of the interactions of Trypanosoma cruzi and Trypanosoma rangeli within the reduviid insect host Rhodnius prolixus. An. Acad. Bras. Cienc. 2005, 77:397-404.
9. Baker N., O'Meara S.J., Scannell M., Maderna P., Godson C. Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. J. Immunol. 2009, 182:3819-3826.
10. Belaunzaran M.L., Wainszelbaum M.J., Lammel E.M., Gimenez G., Aloise M.M., Florin-Christensen J., et al. Phospholipase A1 from Trypanosoma cruzi infective stages generates lipid messengers that activate host cell protein kinase C. Parasitology 2007, 134:491-502.
11. Beller T.C., Friend D.S., Maekawa A., Lam B.K., Austen K.F., Kanaoka Y. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc. Natl. Acad. Sci. USA 2004, 101:3047-3052.
12. Borges M.M., Kloetzel J.K., Andrade H.F., Tadokoro C.E., Pinge-Filho P., Abrahamsohn I. Prostaglandin and nitric oxide regulate TNF-α production during Trypanosoma cruzi infection. Immunol. Lett. 1998, 63:1-8.
13. Borges C.L., Cecchini R., Tatakihara V.L., Malvezi A.D., Yamada-Ogatta S.F., Rizzo L.V., et al. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease. Immunol. Lett. 2009, 123:38-45.
14. Braquet P., Touqui L., Shen T.Y., Vargaftig B.B. Perspectives in platelet-activating factor research. Pharmacol. Rev. 1987, 39:97-145.
15. Brink C., Dahlen S.E., Drazen J., Evans J.F., Hay D.W., Nicosia S., et al. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 2003, 55:195-227.
16. Brock T.G., McNish R.W., Peters-Golden M. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J. Biol. Chem. 1995, 270:21652-21658.
17. Cardoni R.L., Antunez M.I. Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. Mediators Inflamm. 2004, 13:235-240.
18. Catisti R., Uyemura S.A., Docampo R., Vercesi A.E. Calcium mobilization by arachidonic acid in trypanosomatids. Mol. Biochem. Parasitol. 2000, 105:261-271.
19. Celentano A.M., Gorelik G., Solana M.E., Sterin-Borda L., Borda E., Gonzalez Cappa S.M. PGE2 involvement in experimental infection with Trypanosoma cruzi subpopulations. Prostaglandins 1995, 49:141-153.
20. Chandrasekar B., Melby P.C., Troyer D.A., Freeman G.L. Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy. Biochem. Biophys. Res. Commun. 1996, 223:365-371.
21. Chandrasekar B., Melby P.C., Troyer D.A., Colston J.T., Freeman G.L. Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy. Am. J. Pathol. 1998, 152:925-934.
22. Chao W., Olson M.S. Platelet-activating factor: receptors and signal transduction. Biochem. J. 1993, 292(Pt. 3):617-629.
23. Chiang N., Serhan C.N., Dahlen S.E., Drazen J.M., Hay D.W., Rovati G.E., et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 2006, 58:463-487.
24. Chignard M., Le Couedic J.P., Tence M., Vargaftig B.B., Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature 1979, 279:799-800.
25. Chow S.C., Jondal M. Polyunsaturated free fatty acids stimulate an increase in cytosolic Ca2+ by mobilizing the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool in T cells through a mechanism independent of phosphoinositide turnover. J. Biol. Chem. 1990, 265:902-907.
26. Claria J., Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA 1995, 92:9475-9479.
27. Cox F.E. Trypanosoma cruzi: signals for transformation. Nature 1982, 300:685.
28. Dahlen S.E., Bjork J., Hedqvist P., Arfors K.E., Hammarstrom S., Lindgren J.A., et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 1981, 78:3887-3891.
29. de Barros-Mazon S., Guariento M.E., da Silva C.A., Coffman R.L., Abrahamsohn I.A. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease. Clin. Immunol. 2004, 111:137-145.
30. de Bracco M.M., Sterin-Borda L., Fink S., Finiasz M., Borda E. Stimulatory effect of lymphocytes from Chagas' patients on spontaneously beating rat atria. Clin. Exp. Immunol. 1984, 55:405-412.
31. Devchand P.R., Arita M., Hong S., Bannenberg G., Moussignac R.L., Gronert K., et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 2003, 17:652-659.
32. DeWitt D.L., el-Harith E.A., Kraemer S.A., Andrews M.J., Yao E.F., Armstrong R.L., et al. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J. Biol. Chem. 1990, 265:5192-5198.
33. Dost C.K., Saraiva J., Monesi N., Zentgraf U., Engels W., Albuquerque S. Six Trypanosoma cruzi strains characterized by specific gene expression patterns. Parasitol. Res. 2004, 94:134-140.
34. Egan R.W., Paxton J., Kuehl F.A. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J. Biol. Chem. 1976, 251:7329-7335.
35. Eintracht J., Maathai R., Mellors A., Ruben L. Calcium entry in Trypanosoma brucei is regulated by phospholipase A2 and arachidonic acid. Biochem. J. 1998, 336(Pt. 3):659-666.
36. Factor S.M., Cho S., Wittner M., Tanowitz H. Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am. J. Trop. Med. Hyg. 1985, 34:246-253.
37. Figarella K., Rawer M., Uzcategui N.L., Kubata B.K., Lauber K., Madeo F., et al. Prostaglandin D2 induces programmed cell death in Trypanosoma brucei bloodstream form. Cell Death Differ. 2005, 12:335-346.
38. Figarella K., Uzcategui N.L., Beck A., Schoenfeld C., Kubata B.K., Lang F., et al. Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress. Cell Death Differ. 2006, 13:1802-1814.
39. Freire-de-Lima C.G., Nascimento D.O., Soares M.B., Bozza P.T., Castro-Faria-Neto H.C., de Mello F.G., et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 2000, 403:199-203.
40. Garcia E.S., Machado E.M., Azambuja P. Effects of eicosanoid biosynthesis inhibitors on the prophenoloxidase-activating system and microaggregation reactions in the hemolymph of Rhodnius prolixus infected with Trypanosoma rangeli. J. Insect Physiol. 2004, 50:157-165.
41. Gomes M.T., Monteiro R.Q., Grillo L.A., Leite-Lopes F., Stroeder H., Ferreira-Pereira A., et al. Platelet-activating factor-like activity isolated from Trypanosoma cruzi. Int. J. Parasitol. 2006, 36:165-173.
42. Gorelik G., Borda E., Postan M., Gonzalez Cappa S., Sterin-Borda L. T lymphocytes from T. cruzi-infected mice alter heart contractility: participation of arachidonic acid metabolites. J. Mol. Cell. Cardiol. 1992, 24:9-20.
43. Haeggstrom J.Z., Rinaldo-Matthis A., Wheelock C.E., Wetterholm A. Advances in eicosanoid research, novel therapeutic implications. Biochem. Biophys. Res. Commun. 2010, 396:135-139.
44. Ham E.A., Egan R.W., Soderman D.D., Gale P.H., Kuehl F.A. Peroxidase-dependent deactivation of prostacyclin synthetase. J. Biol. Chem. 1979, 254:2191-2194.
45. Hecker M., Ullrich V. On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J. Biol. Chem. 1989, 264:141-150.
46. Henderson W.R., Chi E.Y. The importance of leukotrienes in mast cell-mediated Toxoplasma gondii cytotoxicity. J. Infect. Dis. 1998, 177:1437-1443.
47. Hideko Tatakihara V.L., Cecchini R., Borges C.L., Malvezi A.D., Graca-de Souza V.K., Yamada-Ogatta S.F., et al. Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection. FEMS Immunol. Med. Microbiol. 2008, 52:47-58.
48. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA 1992, 89:7384-7388.
49. Huang H., Calderon T.M., Berman J.W., Braunstein V.L., Weiss L.M., Wittner M., et al. Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect. Immun. 1999, 67:5434-5440.
50. Huang H., Chan J., Wittner M., Jelicks L.A., Morris S.A., Factor S.M., et al. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J. Mol. Cell Cardiol. 1999, 1:75-88.
51. Hui Y., Cheng Y., Smalera I., Jian W., Goldhahn L., Fitzgerald G.A., et al. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 2004, 110:3360-3366.
52. Im S.Y., Ko H.M., Kim J.W., Lee H.K., Ha T.Y., Lee H.B., et al. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res. 1996, 56:2662-2665.
53. Im S.Y., Choi J.H., Ko H.M., Han S.J., Chun S.B., Lee H.K., et al. A protective role of platelet-activating factor in murine candidiasis. Infect. Immun. 1997, 65:1321-1326.
54. Ishii S., Kuwaki T., Nagase T., Maki K., Tashiro F., Sunaga S., et al. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 1998, 187:1779-1788.
55. Ivanov I., Heydeck D., Hofheinz K., Roffeis J., O'Donnell V.B., Kuhn H., et al. Molecular enzymology of lipoxygenases. Arch. Biochem. Biophys. 2010, 503:161-174.
56. Kabashima K., Murata T., Tanaka H., Matsuoka T., Sakata D., Yoshida N., et al. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 2003, 4:694-701.
57. Kabututu Z., Martin S.K., Nozaki T., Kawazu S., Okada T., Munday C.J., et al. Prostaglandin production from arachidonic acid and evidence for a 9,11-endoperoxide prostaglandin H2 reductase in Leishmania. Int. J. Parasitol. 2003, 33:221-228.
58. Karim S., Habib A., Levy-Toledano S., Maclouf J. Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J. Biol. Chem. 1996, 271:12042-12048.
59. Kilunga K.B., Inoue T., Okano Y., Kabututu Z., Martin S.K., Lazarus M., et al. Structural and mutational analysis of Trypanosoma brucei prostaglandin H2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases. J. Biol. Chem. 2005, 280:26371-26382.
60. Konkle M.E., Hargrove T.Y., Kleshchenko Y.Y., von Kries J.P., Ridenour W., Uddin M.J., et al. Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase. J. Med. Chem. 2009, 52:2846-2853.
61. Kristensson K., Nygard M., Bertini G., Bentivoglio M. African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions. Prog. Neurobiol. 2010, 91:152-171.
62. Kubata B.K., Duszenko M., Kabututu Z., Rawer M., Szallies A., Fujimori K., et al. Identification of a novel prostaglandin F2α synthase in Trypanosoma brucei. J. Exp. Med. 2000, 192:1327-1338.
63. Kubata B.K., Kabututu Z., Nozaki T., Munday C.J., Fukuzumi S., Ohkubo K., et al. A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. J. Exp. Med. 2002, 196:1241-1251.
64. Lam B.K., Gagnon L., Austen K.F., Soberman R.J. The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes. J. Biol. Chem. 1990, 265:13438-13441.
65. Lee S.H., Stephens J.L., Paul K.S., Englund P.T. Fatty acid synthesis by elongases in trypanosomes. Cell 2006, 126:691-699.
66. Livore V.I., Tripodi K.E., Uttaro A.D. Elongation of polyunsaturated fatty acids in trypanosomatids. FEBS J. 2007, 274:264-274.
67. Machado E.R., Ueta M.T., Lourenco E.V., Anibal F.F., Sorgi C.A., Soares E.G., et al. Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J. Immunol. 2005, 175:3892-3899.
68. Machado F.S., Aliberti J. Lipoxins as an immune-escape mechanism. Adv. Exp. Med. Biol. 2009, 666:78-87.
69. Machado F.S., Johndrow J.E., Esper L., Dias A., Bafica A., Serhan C.N., et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat. Med. 2006, 12:330-334.
70. Machado F.S., Souto J.T., Rossi M.A., Esper L., Tanowitz H.B., Aliberti J., et al. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect. 2008, 10:1558-1566.
71. Maderna P., Godson C. Lipoxins: resolutionary road. Br. J. Pharmacol. 2009, 158:947-959.
72. Malvezi A.D., Cecchini R., de Souza F., Tadokoro C.E., Rizzo L.V., Pinge-Filho P. Involvement of nitric oxide (NO) and TNF-α in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. FEMS Immunol. Med. Microbiol. 2004, 41:69-77.
73. Meade E.A., Smith W.L., DeWitt D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 1993, 268:6610-6614.
74. Meade E.A., Smith W.L., DeWitt D.L. Expression of the murine prostaglandin (PGH) synthase-1 and PGH synthase-2 isozymes in cos-1 cells. J. Lipid Mediat. 1993, 6:119-129.
75. Michelin M.A., Silva J.S., Cunha F.Q. Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp. Parasitol. 2005, 111:71-79.
76. Miyamoto T., Ogino N., Yamamoto S., Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem. 1976, 251:2629-2636.
77. Momi S., Perito S., Mezzasoma A.M., Bistoni F., Gresele P. Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdum. Exp. Parasitol. 2000, 95:136-143.
78. Moncada S., Vane J.R. The role of prostacyclin in vascular tissue. Fed. Proc. 1979, 38:66-71.
79. Mukherjee S., Machado F.S., Huang H., Oz H.S., Jelicks L.A., Prado C.M., et al. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS one 2011, 6(2). e16959.
80. Murta S.M., Krieger M.A., Montenegro L.R., Campos F.F., Probst C.M., Avila A.R., et al. Deletion of copies of the gene encoding old yellow enzyme (TcOYE), a NAD(P)H flavin oxidoreductase, associates with in vitro-induced benznidazole resistance in Trypanosoma cruzi. Mol. Biochem. Parasitol. 2006, 146:151-162.
81. Naor Z. Is arachidonic acid a second messenger in signal transduction?. Mol. Cell. Endocrinol. 1991, 80:C181-C186.
82. Ohki S., Ogino N., Yamamoto S., Hayaishi O. Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem. 1979, 254:829-836.
83. Okano Y., Inoue T., Kubata B.K., Kabututu Z., Urade Y., Matsumura H., et al. Crystallization and preliminary X-ray crystallographic studies of Trypanosoma brucei prostaglandin F2α synthase. J. Biochem. 2002, 132:859-861.
84. Oliveira L.G., Kuehn C.C., Santos C.D., Toldo M.P., do Prado J.C. Enhanced protection by melatonin and meloxicam combination in experimental infection by Trypanosoma cruzi. Parasite Immunol. 2010, 32:245-251.
85. Opperdoes F.R., van Roy J. The phospholipases of Trypanosoma brucei bloodstream forms and cultured procyclics. Mol. Biochem. Parasitol. 1982, 5:309-319.
86. Paiva C.N., Arras R.H., Lessa L.P., Gibaldi D., Alves L., Metz C.N., et al. Unraveling the lethal synergism between Trypanosoma cruzi infection and LPS: a role for increased macrophage reactivity. Eur. J. Immunol. 2007, 37:1355-1364.
87. Parente L., Perretti M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem. Pharmacol. 2003, 65:153-159.
88. Pavanelli W.R., Gutierrez F.R., Mariano F.S., Prado C.M., Ferreira B.R., Teixeira M.M., et al. 5-Lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes Infect 2010, 8-9:587-597.
89. Petkova S.B., Tanowitz H.B., Magazine H.I., Factor S.M., Chan J., Pestell R.G., et al. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc. Pathol. 2000, 9:257-265.
90. Petkova S.B., Huang H., Factor S.M., Pestell R.G., Bouzahzah B., Jelicks L.A., et al. The role of endothelin in the pathogenesis of Chagas' disease. Int. J. Parasitol. 2001, 31:499-511.
91. Petray P., Rottenberg M.E., Grinstein S., Orn A. Release of nitric oxide during the experimental infection with Trypanosoma cruzi. Parasite Immunol. 1994, 16:193-199.
92. Piguet P.F., Collart M.A., Grau G.E., Kapanci Y., Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 1989, 170:655-663.
93. Pinge-Filho P., Tadokoro C.E., Abrahamsohn I.A. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell. Immunol. 1999, 193:90-98.
94. Portal P., Villamil S.F., Alonso G.D., De Vas M.G., Flawia M.M., Torres H.N., et al. Multiple NADPH-cytochrome P450 reductases from Trypanosoma cruzi suggested role on drug resistance. Mol. Biochem. Parasitol. 2008, 160:42-51.
95. Ridgley E.L., Ruben L. Phospholipase from Trypanosoma brucei releases arachidonic acid by sequential sn-1, sn-2 deacylation of phospholipids. Mol. Biochem. Parasitol. 2001, 114:29-40.
96. Rodrigues C.O., Dutra P.M., Souto-Padron T., Cordeiro R.S., Lopes A.H. Effect of platelet-activating factor on cell differentiation of Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 1996, 223:735-740.
97. Rodrigues W.F., Miguel C.B., Chica J.E., Napimoga M.H. 15d-PGJ2 modulates acute immune responses to Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz 2010, 105:137-143.
98. Rossi M.A. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J. Hypertens. 1998, 16:1031-1041.
99. Rouzer C.A., Marnett L.J. Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J. Biol. Chem. 2008, 283:8065-8069.
100. Ryan A., Godson C. Lipoxins: regulators of resolution. Curr. Opin. Pharmacol. 2010, 10:166-172.
101. Saavedra E., Herrera M., Gao W., Uemura H., Pereira M.A. The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. J. Exp. Med. 1999, 190:1825-1836.
102. Sage L., Hambrey P.N., Werchola G.M., Mellors A., Tizard I.R. Lysophospholipase 1 in Trypanosoma brucei. Tropenmed. Parasitol. 1981, 32:215-220.
103. Santos C.F., Silva M.E., Nicoli J.R., Crocco-Afonso L.C., Santos J.E., Bambirra E.A., et al. Effect of an essential fatty acid deficient diet on experimental infection with Trypanosoma cruzi in germfree and conventional mice. Braz. J. Med. Biol. Res. 1992, 25:795-803.
104. Santovito D., Mezzetti A., Cipollone F. Cyclooxygenase and prostaglandin synthases: roles in plaque stability and instability in humans. Curr. Opin. Lipidol. 2009, 20:402-408.
105. Schaldach C.M., Riby J., Bjeldanes L.F. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 1999, 38:7594-7600.
106. Schultheiss G., Diener M. Inhibition of spontaneous smooth muscle contractions in rat and rabbit intestine by blockers of the thromboxane A2 pathway. Zentralbl. Veterinarmed. A 1999, 46:123-131.
107. Serhan C.N., Hamberg M., Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. USA 1984, 81:5335-5339.
108. Shimokawa T., Smith W.L. Essential histidines of prostaglandin endoperoxide synthase. His309 is involved in heme binding. J. Biol. Chem. 1991, 266:6168-6173.
109. Shimokawa T., Kulmacz R.J., DeWitt D.L., Smith W.L. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. J. Biol. Chem. 1990, 265:20073-20076.
110. Shuaibu M.N., Kanbara H., Yanagi T., Ameh D.A., Bonire J.J., Nok A.J. Phospholipase A2 from Trypanosoma brucei gambiense and Trypanosoma brucei brucei: inhibition by organotins. J. Enzyme Inhib. 2001, 16:433-441.
111. Smith W.L., DeWitt D.L., Shimokawa T. The aspirin and heme binding sites of PGG/H synthase. Adv. Prostaglandin Thromboxane Leukot. Res. 1991, 21A:77-80.
112. Smith W.L., DeWitt D.L., Arakawa T., Spencer A.G., Thuresson E.D., Song I. Independent prostanoid biosynthetic systems associated with prostaglandin endoperoxide synthases-1 and -2. Thromb. Haemost. 1997, 78:627-630.
113. Stables M.J., Gilroy D.W. Old and new generation lipid mediators in acute inflammation and resolution. Prog. Lipid Res. 2010, 50:35-51.
114. Sterin-Borda L., Gorelik G., Goren N., Cappa S.G., Celentano A.M., Borda E. Lymphocyte muscarinic cholinergic activity and PGE2 involvement in experimental Trypanosoma cruzi infection. Clin. Immunol. Immunopathol. 1996, 81:122-128.
115. Stuhlmeier K.M., Tarn C., Csizmadia V., Bach F.H. Selective suppression of endothelial cell activation by arachidonic acid. Eur. J. Immunol. 1996, 26:1417-1423.
116. Sugiyama S., Tokuoka K., Uchiyama N., Okamoto N., Okano Y., Matsumura H., et al. Preparation, crystallization and preliminary crystallographic analysis of old yellow enzyme from Trypanosoma cruzi. Acta Crystallogr. F Struct. Biol. Cryst. Commun. 2007, 63:896-898.
117. Sumida C., Graber R., Nunez E. Role of fatty acids in signal transduction: modulators and messengers. Prostaglandins Leukot. Essent. Fatty Acids 1993, 48:117-122.
118. Tager A.M., Luster A.D. BLT1 and BLT2: the leukotriene B4 receptors. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:123-134.
119. Tager A.M., Bromley S.K., Medoff B.D., Islam S.A., Bercury S.D., Friedrich E.B., et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 2003, 4:982-990.
120. Talvani A., Machado F.S., Santana G.C., Klein A., Barcelos L., Silva J.S., et al. Leukotriene B4 induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect. Immun. 2002, 70:4247-4253.
121. Tanowitz H.B., Burns E.R., Sinha A.K., Kahn N.N., Morris S.A., Factor S.M., et al. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am. J. Trop. Med. Hyg. 1990, 43:274-281.
122. Tanowitz H.B., Kirchhoff L.V., Simon D., Morris S.A., Weiss L.M., Wittner M. Chagas' disease. Clin. Microbiol. Rev. 1992, 5:400-419.
123. Tanowitz H.B., Kaul D.K., Chen B., Morris S.A., Factor S.M., Weiss L.M., et al. Compromised microcirculation in acute murine Trypanosoma cruzi infection. J. Parasitol. 1996, 82:124-130.
124. Tanowitz H.B., Huang H., Jelicks L.A., Chandra M., Loredo M.L., Weiss L.M., et al. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect. Immun. 2005, 73:2496-2503.
125. Tanowitz H.B., Machado F.S., Jelicks L.A., Shirani J., de Carvalho A.C., Spray D.C., et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog. Cardiovasc. Dis. 2009, 51:524-539.
126. Toh H. Prostaglandin endoperoxide synthase contains an EGF-like domain. FEBS Lett. 1989, 258:317-319.
127. Truyens C., Angelo-Barrios A., Torrico F., Van Damme J., Heremans H., Carlier Y. Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses. Infect. Immun. 1994, 62:692-696.
128. Vespa G.N., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 1994, 62:5177-5182.
129. Wainszelbaum M.J., Belaunzaran M.L., Lammel E.M., Florin-Christensen M., Florin-Christensen J., Isola E.L. Free fatty acids induce cell differentiation to infective forms in Trypanosoma cruzi. Biochem. J. 2003, 375:705-712.
130. Walt R.P., Kemp R.T., Filipowicz B., Davies J.G., Bhaskar N.K., Hawkey C.J. Gastric mucosal protection with selective inhibition of thromboxane synthesis. Gut 1987, 28:541-544.
131. Wirth J.J., Kierszenbaum F. Effects of leukotriene C4 on macrophage association with and intracellular fate of Trypanosoma cruzi. Mol. Biochem. Parasitol. 1985, 15:1-10.
132. Wirth J.J., Kierszenbaum F. Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi. J. Immunol. 1985, 134:1989-1993.
133. Wu K.K., Hatzakis H., Lo S.S., Seong D.C., Sanduja S.K., Tai H.H. Stimulation of de novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol ester. J. Biol. Chem. 1988, 263:19043-19047.
134. Yamaguchi K., Okamoto N., Tokuoka K., Sugiyama S., Uchiyama N., Matsumura H., et al. Structure of the inhibitor complex of old yellow enzyme from Trypanosoma cruzi. J. Synchrotron Radiat. 2011, 18:66-69.
135. Yokoyama C., Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem. Biophys. Res. Commun. 1989, 165:888-894.
136. Zuniga E., Acosta-Rodriguez E., Merino M.C., Montes C., Gruppi A. Depletion of immature B cells during Trypanosoma cruzi infection: involvement of myeloid cells and the cyclooxygenase pathway. Eur. J. Immunol. 2005, 35:1849-1858.